Cargando…

Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting

Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as T(1) and T(2) mapping, is promising for improving tumor assessment beyond conventional qualitative T(1)- and T(2)-weighte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaggie, Joshua D., Deen, Surrin, Kessler, Dimitri A., McLean, Mary A., Buonincontri, Guido, Schulte, Rolf F., Addley, Helen, Sala, Evis, Brenton, James, Graves, Martin J., Gallagher, Ferdia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025887/
https://www.ncbi.nlm.nih.gov/pubmed/32066996
http://dx.doi.org/10.1109/TRPMS.2019.2905366
_version_ 1783498579081428992
author Kaggie, Joshua D.
Deen, Surrin
Kessler, Dimitri A.
McLean, Mary A.
Buonincontri, Guido
Schulte, Rolf F.
Addley, Helen
Sala, Evis
Brenton, James
Graves, Martin J.
Gallagher, Ferdia A.
author_facet Kaggie, Joshua D.
Deen, Surrin
Kessler, Dimitri A.
McLean, Mary A.
Buonincontri, Guido
Schulte, Rolf F.
Addley, Helen
Sala, Evis
Brenton, James
Graves, Martin J.
Gallagher, Ferdia A.
author_sort Kaggie, Joshua D.
collection PubMed
description Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as T(1) and T(2) mapping, is promising for improving tumor assessment beyond conventional qualitative T(1)- and T(2)-weighted images. However, quantitative MRI relaxation mapping methods often involve long scan times due to sequentially measuring many parameters. Magnetic resonance fingerprinting (MRF) is a new method that enables fast quantitative MRI by exploiting the transient signals caused by the variation of pseudorandom sequence parameters. These transient signals are then matched to a simulated dictionary of T(1) and T(2) values to create quantitative maps. The ability of MRF to simultaneously measure multiple parameters, could represent a new approach to characterizing cancer and assessing treatment response. This feasibility study investigates MRF for simultaneous T(1), T(2), and relative proton density (rPD) mapping using ovarian cancer as a model system.
format Online
Article
Text
id pubmed-7025887
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-70258872020-02-17 Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting Kaggie, Joshua D. Deen, Surrin Kessler, Dimitri A. McLean, Mary A. Buonincontri, Guido Schulte, Rolf F. Addley, Helen Sala, Evis Brenton, James Graves, Martin J. Gallagher, Ferdia A. IEEE Trans Radiat Plasma Med Sci Article Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as T(1) and T(2) mapping, is promising for improving tumor assessment beyond conventional qualitative T(1)- and T(2)-weighted images. However, quantitative MRI relaxation mapping methods often involve long scan times due to sequentially measuring many parameters. Magnetic resonance fingerprinting (MRF) is a new method that enables fast quantitative MRI by exploiting the transient signals caused by the variation of pseudorandom sequence parameters. These transient signals are then matched to a simulated dictionary of T(1) and T(2) values to create quantitative maps. The ability of MRF to simultaneously measure multiple parameters, could represent a new approach to characterizing cancer and assessing treatment response. This feasibility study investigates MRF for simultaneous T(1), T(2), and relative proton density (rPD) mapping using ovarian cancer as a model system. 2019-03-15 2019-07 /pmc/articles/PMC7025887/ /pubmed/32066996 http://dx.doi.org/10.1109/TRPMS.2019.2905366 Text en http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License. For more information, see http://creativecommons.org/licenses/by/3.0/
spellingShingle Article
Kaggie, Joshua D.
Deen, Surrin
Kessler, Dimitri A.
McLean, Mary A.
Buonincontri, Guido
Schulte, Rolf F.
Addley, Helen
Sala, Evis
Brenton, James
Graves, Martin J.
Gallagher, Ferdia A.
Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting
title Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting
title_full Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting
title_fullStr Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting
title_full_unstemmed Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting
title_short Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting
title_sort feasibility of quantitative magnetic resonance fingerprinting in ovarian tumors for t(1) and t(2) mapping in a pet/mr setting
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025887/
https://www.ncbi.nlm.nih.gov/pubmed/32066996
http://dx.doi.org/10.1109/TRPMS.2019.2905366
work_keys_str_mv AT kaggiejoshuad feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT deensurrin feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT kesslerdimitria feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT mcleanmarya feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT buonincontriguido feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT schulterolff feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT addleyhelen feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT salaevis feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT brentonjames feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT gravesmartinj feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting
AT gallagherferdiaa feasibilityofquantitativemagneticresonancefingerprintinginovariantumorsfort1andt2mappinginapetmrsetting